|
Art Gertel, Vice President of Clinical Services, Regulatory, and Medical Writing, has more than 25 years of experience in the pharmaceutical industry. Art has had a broad range of primarily management-level responsibility in virtually all phases of pharmaceutical drug research and development, from preclinical pathology/toxicology to registrational clinical trials, post-marketing trials, project management, and market support. His most recent experiences include directing the Medical Communications Department at Schering-Plough, with responsibility for preparing all new drug applications, worldwide; and heading the Project and Portfolio Management functions of the Advanced Phase (Phases IIIb and IV) group at Quintiles. In addition, he recently headed the clinical trials operations at iKnowMed, with the charge of applying the company�s electronic data capture technology to pharmaceutical clinical trials. He received undergraduate education in Biology and Psychology at the University of Pennsylvania and pursued graduate studies in Behavioral Medicine at New York Medical College, and Pharmaceutics at Temple University. He served as President of the American Medical Writers Association (AMWA): a biomedical communications professional association comprising more than 4,000 members, worldwide. He is a frequent lecturer and teacher at Drug Information Association (DIA), European Medical Writers Association (EMWA) and AMWA meetings and is very active in the Clinical Data Interchange Standards Consortium (CDISC) efforts to standardize clinical data. Art is a Fellow of AMWA and EMWA. | 